OHI

+ Watchlist + Portfolio

Omega Healthcare Investors, Inc.

Regulated industry Sells to businessesTags from an AI model reading the company description.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $45.23
52-Week Range: $39.26 – $52.39
Market Cap: $14.42B
P/E (TTM): 16.33
EPS (TTM): 2.80
Dividend Yield: 5.95%

Advanced Metrics

Price/Book: 2.54
PEG Ratio: 11.99
Return on Equity: 16.53%
Return on Assets: 4.91%
Gross Margin: 97.92%
Operating Margin: 61.49%
Profit Margin: 68.05%
Current Ratio: 0.44
Debt/Equity: 0.71
Total Debt: $4.03B
Free Cash Flow: $665.50M
Revenue Growth: 11.20%
Earnings Growth: 161.30%
Enterprise Value: $18.10B

OHI Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$878.24M	$949.74M	$1.05B	$1.19B
Cost of Revenue	$15.50M	$15.03M	$14.56M	$14.44M
Gross Profit	$862.74M	$934.72M	$1.04B	$1.18B
Selling, General & Admin	$69.40M	$81.50M	$88.00M	$104.14M
Operating Expenses	$470.47M	$445.74M	$377.17M	$431.72M
Operating Income	$392.28M	$488.97M	$659.66M	$743.94M
EBITDA	$1.00B	$810.84M	$947.11M	$1.16B
Pretax Income	$436.14M	$255.63M	$420.75M	$624.43M
Income Tax	$4.56M	$6.25M	$10.86M	$14.75M
Net Income	$426.93M	$242.18M	$406.33M	$590.18M
Diluted EPS	1.80	1.00	1.55	1.94
Diluted Shares	244.29M	250.45M	270.45M	304.95M

OHI Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$297.10M	$442.81M	$518.34M	$27.02M
Receivables	$1.46B	$1.72B	$2.03B	$2.00B
Current Assets	$1.77B	$2.23B	$2.64B	$2.06B
Total Assets	$9.41B	$9.12B	$9.90B	$10.05B
Current Liabilities	$334.29M	$308.19M	$328.19M	$594.55M
Long-Term Debt	$5.27B	$5.05B	$4.84B	$4.01B
Total Debt	$5.29B	$5.07B	$4.84B	$4.26B
Total Liabilities	$5.60B	$5.36B	$5.17B	$4.61B
Retained Earnings	-$2.75B	-$3.15B	-$3.43B	-$3.62B
Shareholders' Equity	$3.61B	$3.57B	$4.54B	$5.18B
Working Capital	$1.44B	$1.93B	$2.31B	$1.46B
Net Debt	$4.99B	$4.62B	$4.32B	$4.23B

OHI Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	$625.73M	$617.74M	$749.43M	$878.55M
Free Cash Flow	$625.73M	$617.74M	$749.43M	$878.55M
Depreciation & Amortisation	$332.41M	$319.68M	$304.65M	$325.25M
Stock-Based Compensation	$27.30M	$35.07M	$36.70M	$44.19M
Investing Cash Flow	$442.85M	-$770.00K	-$671.16M	-$539.79M
Financing Cash Flow	-$789.45M	-$473.31M	$26.32M	-$838.26M
Dividends Paid	-$632.89M	-$643.87M	-$685.45M	-$780.39M
Share Repurchases	-$142.27M	$0.00	$0.00	—
Net Change in Cash	$279.13M	$143.66M	$104.58M	-$499.50M

OHI Income statement, quarterly periods, in USD
USD	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Revenue	$282.51M	$311.59M	$319.22M	$322.95M	$328.25M
Cost of Revenue	$3.77M	$3.50M	$4.37M	$9.01M	$16.20M
Gross Profit	$278.74M	$308.09M	$314.84M	$313.94M	$312.05M
Selling, General & Admin	$23.32M	$23.78M	$24.46M	$26.02M	$42.00M
Operating Expenses	$99.06M	$101.98M	$113.14M	$106.87M	$118.82M
Operating Income	$179.68M	$206.10M	$201.71M	$207.08M	$193.23M
EBITDA	$280.60M	$331.58M	$305.79M	$293.81M	$509.71M
Pretax Income	$147.19M	$191.35M	$171.30M	$159.92M	$379.76M
Income Tax	$4.53M	$4.48M	$2.13M	$5.11M	$4.62M
Net Income	$136.60M	$179.72M	$164.84M	$151.05M	$362.82M
Diluted EPS	0.46	0.59	0.55	0.47	1.19
Diluted Shares	303.25M	308.17M	313.23M	315.13M	316.25M

OHI Balance Sheet statement, quarterly periods, in USD
USD	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Cash & Equivalents	$734.18M	$737.19M	$27.02M	$26.15M	$39.04M
Receivables	$2.02B	$2.03B	$2.00B	$2.04B	$1.91B
Current Assets	$2.80B	$2.81B	$2.06B	$2.32B	$2.10B
Total Assets	$10.55B	$10.60B	$10.05B	$10.23B	$10.01B
Current Liabilities	$357.04M	$357.39M	$594.55M	$763.24M	$353.86M
Long-Term Debt	$5.00B	$4.99B	$4.01B	$4.02B	$4.02B
Total Debt	$5.00B	$4.99B	$4.26B	$4.44B	$4.02B
Total Liabilities	$5.36B	$5.35B	$4.61B	$4.78B	$4.37B
Retained Earnings	-$3.57B	-$3.59B	-$3.62B	-$3.67B	-$3.51B
Shareholders' Equity	$4.99B	$5.04B	$5.18B	$5.19B	$5.39B
Working Capital	$2.45B	$2.45B	$1.46B	$1.56B	$1.74B
Net Debt	$4.27B	$4.26B	$4.23B	$4.42B	$3.99B

OHI Cash Flow statement, quarterly periods, in USD
USD	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Operating Cash Flow	$239.26M	$226.71M	$230.62M	$215.50M	$217.72M
Free Cash Flow	$239.26M	$226.71M	$230.62M	$215.50M	$217.72M
Depreciation & Amortisation	$80.51M	$82.11M	$82.75M	$84.14M	$81.84M
Stock-Based Compensation	$9.23M	$9.28M	$9.87M	$10.59M	$23.45M
Investing Cash Flow	-$463.55M	-$83.80M	-$11.71M	-$270.01M	$552.05M
Financing Cash Flow	$588.96M	-$139.05M	-$940.46M	$54.32M	-$639.14M
Dividends Paid	-$194.57M	-$198.21M	-$198.39M	-$198.42M	-$200.03M
Net Change in Cash	$364.67M	$3.87M	-$721.55M	-$188.00K	$130.63M

Market Snapshot

About

Omega Healthcare Investors, Inc. is a real estate investment trust specializing in skilled nursing and assisted living facilities. The REIT invests in healthcare facilities across the United States, primarily through sale-leaseback transactions and mortgage financing to experienced operators.